Global Attention Deficit Hyperactivity Disorder (ADHD) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Attention Deficit Hyperactivity Disorder (ADHD) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 113

Published Date: 02 Jan 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

According to our (Global Info Research) latest study, the global Attention Deficit Hyperactivity Disorder (ADHD) market size was valued at USD 12590 million in 2023 and is forecast to a readjusted size of USD 19460 million by 2030 with a CAGR of 6.4% during review period.

Effective treatment of ADHD. ADHD refers to a group of syndromes that occur in childhood and are characterized by obvious difficulty in concentration, short duration of attention, hyperactivity or impulsivity compared with children of the same age.

There are two main types of drugs used to treat ADHD: stimulants and non-stimulants
The main manufacturers of stimulants are in Europe and America, and the main manufacturers of non-stimulants are in China.

ADHD is mainly used in hospital pharmacies and retail pharmacies. Among them, in 2020, the market share of retail pharmacies accounted for approximately 83%
Takeda has the highest market share in ADHD by major global companies, which is much higher than the market share of other companies, about 21% in 2020.

The Global Info Research report includes an overview of the development of the Attention Deficit Hyperactivity Disorder (ADHD) industry chain, the market status of Hospital Pharmacy (Stimulant, Non-stimulant), Retail Pharmacy (Stimulant, Non-stimulant), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Attention Deficit Hyperactivity Disorder (ADHD).

Regionally, the report analyzes the Attention Deficit Hyperactivity Disorder (ADHD) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Attention Deficit Hyperactivity Disorder (ADHD) market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Attention Deficit Hyperactivity Disorder (ADHD) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Attention Deficit Hyperactivity Disorder (ADHD) industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Stimulant, Non-stimulant).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Attention Deficit Hyperactivity Disorder (ADHD) market.

Regional Analysis: The report involves examining the Attention Deficit Hyperactivity Disorder (ADHD) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Attention Deficit Hyperactivity Disorder (ADHD) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Attention Deficit Hyperactivity Disorder (ADHD):
Company Analysis: Report covers individual Attention Deficit Hyperactivity Disorder (ADHD) players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Attention Deficit Hyperactivity Disorder (ADHD) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Distribution Channel (Hospital Pharmacy, Retail Pharmacy).

Technology Analysis: Report covers specific technologies relevant to Attention Deficit Hyperactivity Disorder (ADHD). It assesses the current state, advancements, and potential future developments in Attention Deficit Hyperactivity Disorder (ADHD) areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Attention Deficit Hyperactivity Disorder (ADHD) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Attention Deficit Hyperactivity Disorder (ADHD) market is split by Type and by Distribution Channel. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Distribution Channel in terms of value.

Market segment by Type
Stimulant
Non-stimulant

Market segment by Distribution Channel
Hospital Pharmacy
Retail Pharmacy

Market segment by players, this report covers
Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
CTFH

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Attention Deficit Hyperactivity Disorder (ADHD) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Attention Deficit Hyperactivity Disorder (ADHD), with revenue, gross margin and global market share of Attention Deficit Hyperactivity Disorder (ADHD) from 2019 to 2024.
Chapter 3, the Attention Deficit Hyperactivity Disorder (ADHD) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Attention Deficit Hyperactivity Disorder (ADHD) market forecast, by regions, type and distribution channel, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Attention Deficit Hyperactivity Disorder (ADHD).
Chapter 13, to describe Attention Deficit Hyperactivity Disorder (ADHD) research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Attention Deficit Hyperactivity Disorder (ADHD)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Attention Deficit Hyperactivity Disorder (ADHD) by Type
1.3.1 Overview: Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Type in 2023
1.3.3 Stimulant
1.3.4 Non-stimulant
1.4 Global Attention Deficit Hyperactivity Disorder (ADHD) Market by Distribution Channel
1.4.1 Overview: Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacy
1.4.3 Retail Pharmacy
1.5 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size & Forecast
1.6 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast by Region
1.6.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region, (2019-2030)
1.6.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Prospect (2019-2030)
1.6.4 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Prospect (2019-2030)
1.6.6 South America Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Prospect (2019-2030)

2 Company Profiles
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
2.1.4 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Takeda Recent Developments and Future Plans
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
2.2.4 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Johnson & Johnson Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
2.3.4 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Eli Lilly
2.4.1 Eli Lilly Details
2.4.2 Eli Lilly Major Business
2.4.3 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
2.4.4 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Eli Lilly Recent Developments and Future Plans
2.5 Tris Pharma
2.5.1 Tris Pharma Details
2.5.2 Tris Pharma Major Business
2.5.3 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
2.5.4 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Tris Pharma Recent Developments and Future Plans
2.6 Neos Therapeutics
2.6.1 Neos Therapeutics Details
2.6.2 Neos Therapeutics Major Business
2.6.3 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
2.6.4 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Neos Therapeutics Recent Developments and Future Plans
2.7 Mallinckrodt
2.7.1 Mallinckrodt Details
2.7.2 Mallinckrodt Major Business
2.7.3 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
2.7.4 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Mallinckrodt Recent Developments and Future Plans
2.8 Amneal Pharmaceuticals
2.8.1 Amneal Pharmaceuticals Details
2.8.2 Amneal Pharmaceuticals Major Business
2.8.3 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
2.8.4 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Amneal Pharmaceuticals Recent Developments and Future Plans
2.9 Noven Pharmaceuticals
2.9.1 Noven Pharmaceuticals Details
2.9.2 Noven Pharmaceuticals Major Business
2.9.3 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
2.9.4 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Noven Pharmaceuticals Recent Developments and Future Plans
2.10 Purdue Parma
2.10.1 Purdue Parma Details
2.10.2 Purdue Parma Major Business
2.10.3 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
2.10.4 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Purdue Parma Recent Developments and Future Plans
2.11 CTFH
2.11.1 CTFH Details
2.11.2 CTFH Major Business
2.11.3 CTFH Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
2.11.4 CTFH Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 CTFH Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Attention Deficit Hyperactivity Disorder (ADHD) by Company Revenue
3.2.2 Top 3 Attention Deficit Hyperactivity Disorder (ADHD) Players Market Share in 2023
3.2.3 Top 6 Attention Deficit Hyperactivity Disorder (ADHD) Players Market Share in 2023
3.3 Attention Deficit Hyperactivity Disorder (ADHD) Market: Overall Company Footprint Analysis
3.3.1 Attention Deficit Hyperactivity Disorder (ADHD) Market: Region Footprint
3.3.2 Attention Deficit Hyperactivity Disorder (ADHD) Market: Company Product Type Footprint
3.3.3 Attention Deficit Hyperactivity Disorder (ADHD) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value and Market Share by Type (2019-2024)
4.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast by Type (2025-2030)

5 Market Size Segment by Distribution Channel
5.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Distribution Channel (2019-2024)
5.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast by Distribution Channel (2025-2030)

6 North America
6.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2019-2030)
6.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2019-2030)
6.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country
6.3.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Country (2019-2030)
6.3.2 United States Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
6.3.3 Canada Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
6.3.4 Mexico Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)

7 Europe
7.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2019-2030)
7.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2019-2030)
7.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country
7.3.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Country (2019-2030)
7.3.2 Germany Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
7.3.3 France Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
7.3.5 Russia Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
7.3.6 Italy Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)

8 Asia-Pacific
8.1 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2019-2030)
8.3 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region
8.3.1 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Region (2019-2030)
8.3.2 China Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
8.3.3 Japan Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
8.3.4 South Korea Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
8.3.5 India Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
8.3.7 Australia Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)

9 South America
9.1 South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2019-2030)
9.2 South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2019-2030)
9.3 South America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country
9.3.1 South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Country (2019-2030)
9.3.2 Brazil Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
9.3.3 Argentina Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)

10 Middle East & Africa
10.1 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2019-2030)
10.3 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country
10.3.1 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Country (2019-2030)
10.3.2 Turkey Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
10.3.4 UAE Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)

11 Market Dynamics
11.1 Attention Deficit Hyperactivity Disorder (ADHD) Market Drivers
11.2 Attention Deficit Hyperactivity Disorder (ADHD) Market Restraints
11.3 Attention Deficit Hyperactivity Disorder (ADHD) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry

12 Industry Chain Analysis
12.1 Attention Deficit Hyperactivity Disorder (ADHD) Industry Chain
12.2 Attention Deficit Hyperactivity Disorder (ADHD) Upstream Analysis
12.3 Attention Deficit Hyperactivity Disorder (ADHD) Midstream Analysis
12.4 Attention Deficit Hyperactivity Disorder (ADHD) Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel, (USD Million), 2019 & 2023 & 2030
Table 3. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Takeda Company Information, Head Office, and Major Competitors
Table 6. Takeda Major Business
Table 7. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 8. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Takeda Recent Developments and Future Plans
Table 10. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 11. Johnson & Johnson Major Business
Table 12. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 13. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Johnson & Johnson Recent Developments and Future Plans
Table 15. Novartis Company Information, Head Office, and Major Competitors
Table 16. Novartis Major Business
Table 17. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 18. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Novartis Recent Developments and Future Plans
Table 20. Eli Lilly Company Information, Head Office, and Major Competitors
Table 21. Eli Lilly Major Business
Table 22. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 23. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Eli Lilly Recent Developments and Future Plans
Table 25. Tris Pharma Company Information, Head Office, and Major Competitors
Table 26. Tris Pharma Major Business
Table 27. Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 28. Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Tris Pharma Recent Developments and Future Plans
Table 30. Neos Therapeutics Company Information, Head Office, and Major Competitors
Table 31. Neos Therapeutics Major Business
Table 32. Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 33. Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Neos Therapeutics Recent Developments and Future Plans
Table 35. Mallinckrodt Company Information, Head Office, and Major Competitors
Table 36. Mallinckrodt Major Business
Table 37. Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 38. Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Mallinckrodt Recent Developments and Future Plans
Table 40. Amneal Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 41. Amneal Pharmaceuticals Major Business
Table 42. Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 43. Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Amneal Pharmaceuticals Recent Developments and Future Plans
Table 45. Noven Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 46. Noven Pharmaceuticals Major Business
Table 47. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 48. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Noven Pharmaceuticals Recent Developments and Future Plans
Table 50. Purdue Parma Company Information, Head Office, and Major Competitors
Table 51. Purdue Parma Major Business
Table 52. Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 53. Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Purdue Parma Recent Developments and Future Plans
Table 55. CTFH Company Information, Head Office, and Major Competitors
Table 56. CTFH Major Business
Table 57. CTFH Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 58. CTFH Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. CTFH Recent Developments and Future Plans
Table 60. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million) by Players (2019-2024)
Table 61. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Players (2019-2024)
Table 62. Breakdown of Attention Deficit Hyperactivity Disorder (ADHD) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Attention Deficit Hyperactivity Disorder (ADHD), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 64. Head Office of Key Attention Deficit Hyperactivity Disorder (ADHD) Players
Table 65. Attention Deficit Hyperactivity Disorder (ADHD) Market: Company Product Type Footprint
Table 66. Attention Deficit Hyperactivity Disorder (ADHD) Market: Company Product Application Footprint
Table 67. Attention Deficit Hyperactivity Disorder (ADHD) New Market Entrants and Barriers to Market Entry
Table 68. Attention Deficit Hyperactivity Disorder (ADHD) Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (USD Million) by Type (2019-2024)
Table 70. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Share by Type (2019-2024)
Table 71. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Forecast by Type (2025-2030)
Table 72. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2019-2024)
Table 73. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Forecast by Distribution Channel (2025-2030)
Table 74. North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2019-2024) & (USD Million)
Table 75. North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2025-2030) & (USD Million)
Table 76. North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2019-2024) & (USD Million)
Table 77. North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2025-2030) & (USD Million)
Table 78. North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Country (2019-2024) & (USD Million)
Table 79. North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Country (2025-2030) & (USD Million)
Table 80. Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2019-2024) & (USD Million)
Table 83. Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2025-2030) & (USD Million)
Table 84. Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2019-2024) & (USD Million)
Table 87. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2025-2030) & (USD Million)
Table 88. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2019-2024) & (USD Million)
Table 89. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2025-2030) & (USD Million)
Table 90. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Region (2019-2024) & (USD Million)
Table 91. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Region (2025-2030) & (USD Million)
Table 92. South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2019-2024) & (USD Million)
Table 93. South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2025-2030) & (USD Million)
Table 94. South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2019-2024) & (USD Million)
Table 95. South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2025-2030) & (USD Million)
Table 96. South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Country (2019-2024) & (USD Million)
Table 97. South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2019-2024) & (USD Million)
Table 99. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2025-2030) & (USD Million)
Table 100. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2019-2024) & (USD Million)
Table 101. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2025-2030) & (USD Million)
Table 102. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Country (2019-2024) & (USD Million)
Table 103. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Country (2025-2030) & (USD Million)
Table 104. Attention Deficit Hyperactivity Disorder (ADHD) Raw Material
Table 105. Key Suppliers of Attention Deficit Hyperactivity Disorder (ADHD) Raw Materials
List of Figures
Figure 1. Attention Deficit Hyperactivity Disorder (ADHD) Picture
Figure 2. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Type in 2023
Figure 4. Stimulant
Figure 5. Non-stimulant
Figure 6. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Distribution Channel in 2023
Figure 8. Hospital Pharmacy Picture
Figure 9. Retail Pharmacy Picture
Figure 10. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Market Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 13. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Region (2019-2030)
Figure 14. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Region in 2023
Figure 15. North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 16. Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 17. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 18. South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 19. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 20. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Players in 2023
Figure 21. Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 22. Global Top 3 Players Attention Deficit Hyperactivity Disorder (ADHD) Market Share in 2023
Figure 23. Global Top 6 Players Attention Deficit Hyperactivity Disorder (ADHD) Market Share in 2023
Figure 24. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Share by Type (2019-2024)
Figure 25. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share Forecast by Type (2025-2030)
Figure 26. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Share by Distribution Channel (2019-2024)
Figure 27. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share Forecast by Distribution Channel (2025-2030)
Figure 28. North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Type (2019-2030)
Figure 29. North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Distribution Channel (2019-2030)
Figure 30. North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Country (2019-2030)
Figure 31. United States Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 32. Canada Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 33. Mexico Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 34. Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Type (2019-2030)
Figure 35. Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Distribution Channel (2019-2030)
Figure 36. Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Country (2019-2030)
Figure 37. Germany Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 38. France Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 39. United Kingdom Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 40. Russia Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 41. Italy Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 42. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Type (2019-2030)
Figure 43. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Distribution Channel (2019-2030)
Figure 44. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Region (2019-2030)
Figure 45. China Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 46. Japan Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 47. South Korea Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 48. India Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 49. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 50. Australia Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 51. South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Type (2019-2030)
Figure 52. South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Distribution Channel (2019-2030)
Figure 53. South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Country (2019-2030)
Figure 54. Brazil Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 55. Argentina Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 56. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Type (2019-2030)
Figure 57. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Distribution Channel (2019-2030)
Figure 58. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Country (2019-2030)
Figure 59. Turkey Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 60. Saudi Arabia Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 61. UAE Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 62. Attention Deficit Hyperactivity Disorder (ADHD) Market Drivers
Figure 63. Attention Deficit Hyperactivity Disorder (ADHD) Market Restraints
Figure 64. Attention Deficit Hyperactivity Disorder (ADHD) Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Attention Deficit Hyperactivity Disorder (ADHD) in 2023
Figure 67. Manufacturing Process Analysis of Attention Deficit Hyperactivity Disorder (ADHD)
Figure 68. Attention Deficit Hyperactivity Disorder (ADHD) Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
CTFH
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Attention Deficit Hyperactivity Disorder (ADHD) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Attention Deficit Hyperactivity Disorder (ADHD) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 113

Published Date: 02 Jan 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

According to our (Global Info Research) latest study, the global Attention Deficit Hyperactivity Disorder (ADHD) market size was valued at USD 12590 million in 2023 and is forecast to a readjusted size of USD 19460 million by 2030 with a CAGR of 6.4% during review period.

Effective treatment of ADHD. ADHD refers to a group of syndromes that occur in childhood and are characterized by obvious difficulty in concentration, short duration of attention, hyperactivity or impulsivity compared with children of the same age.

There are two main types of drugs used to treat ADHD: stimulants and non-stimulants
The main manufacturers of stimulants are in Europe and America, and the main manufacturers of non-stimulants are in China.

ADHD is mainly used in hospital pharmacies and retail pharmacies. Among them, in 2020, the market share of retail pharmacies accounted for approximately 83%
Takeda has the highest market share in ADHD by major global companies, which is much higher than the market share of other companies, about 21% in 2020.

The Global Info Research report includes an overview of the development of the Attention Deficit Hyperactivity Disorder (ADHD) industry chain, the market status of Hospital Pharmacy (Stimulant, Non-stimulant), Retail Pharmacy (Stimulant, Non-stimulant), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Attention Deficit Hyperactivity Disorder (ADHD).

Regionally, the report analyzes the Attention Deficit Hyperactivity Disorder (ADHD) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Attention Deficit Hyperactivity Disorder (ADHD) market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Attention Deficit Hyperactivity Disorder (ADHD) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Attention Deficit Hyperactivity Disorder (ADHD) industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Stimulant, Non-stimulant).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Attention Deficit Hyperactivity Disorder (ADHD) market.

Regional Analysis: The report involves examining the Attention Deficit Hyperactivity Disorder (ADHD) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Attention Deficit Hyperactivity Disorder (ADHD) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Attention Deficit Hyperactivity Disorder (ADHD):
Company Analysis: Report covers individual Attention Deficit Hyperactivity Disorder (ADHD) players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Attention Deficit Hyperactivity Disorder (ADHD) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Distribution Channel (Hospital Pharmacy, Retail Pharmacy).

Technology Analysis: Report covers specific technologies relevant to Attention Deficit Hyperactivity Disorder (ADHD). It assesses the current state, advancements, and potential future developments in Attention Deficit Hyperactivity Disorder (ADHD) areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Attention Deficit Hyperactivity Disorder (ADHD) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Attention Deficit Hyperactivity Disorder (ADHD) market is split by Type and by Distribution Channel. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Distribution Channel in terms of value.

Market segment by Type
Stimulant
Non-stimulant

Market segment by Distribution Channel
Hospital Pharmacy
Retail Pharmacy

Market segment by players, this report covers
Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
CTFH

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Attention Deficit Hyperactivity Disorder (ADHD) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Attention Deficit Hyperactivity Disorder (ADHD), with revenue, gross margin and global market share of Attention Deficit Hyperactivity Disorder (ADHD) from 2019 to 2024.
Chapter 3, the Attention Deficit Hyperactivity Disorder (ADHD) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Attention Deficit Hyperactivity Disorder (ADHD) market forecast, by regions, type and distribution channel, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Attention Deficit Hyperactivity Disorder (ADHD).
Chapter 13, to describe Attention Deficit Hyperactivity Disorder (ADHD) research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Attention Deficit Hyperactivity Disorder (ADHD)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Attention Deficit Hyperactivity Disorder (ADHD) by Type
1.3.1 Overview: Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Type in 2023
1.3.3 Stimulant
1.3.4 Non-stimulant
1.4 Global Attention Deficit Hyperactivity Disorder (ADHD) Market by Distribution Channel
1.4.1 Overview: Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacy
1.4.3 Retail Pharmacy
1.5 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size & Forecast
1.6 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast by Region
1.6.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region, (2019-2030)
1.6.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Prospect (2019-2030)
1.6.4 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Prospect (2019-2030)
1.6.6 South America Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Prospect (2019-2030)

2 Company Profiles
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
2.1.4 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Takeda Recent Developments and Future Plans
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
2.2.4 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Johnson & Johnson Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
2.3.4 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Eli Lilly
2.4.1 Eli Lilly Details
2.4.2 Eli Lilly Major Business
2.4.3 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
2.4.4 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Eli Lilly Recent Developments and Future Plans
2.5 Tris Pharma
2.5.1 Tris Pharma Details
2.5.2 Tris Pharma Major Business
2.5.3 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
2.5.4 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Tris Pharma Recent Developments and Future Plans
2.6 Neos Therapeutics
2.6.1 Neos Therapeutics Details
2.6.2 Neos Therapeutics Major Business
2.6.3 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
2.6.4 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Neos Therapeutics Recent Developments and Future Plans
2.7 Mallinckrodt
2.7.1 Mallinckrodt Details
2.7.2 Mallinckrodt Major Business
2.7.3 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
2.7.4 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Mallinckrodt Recent Developments and Future Plans
2.8 Amneal Pharmaceuticals
2.8.1 Amneal Pharmaceuticals Details
2.8.2 Amneal Pharmaceuticals Major Business
2.8.3 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
2.8.4 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Amneal Pharmaceuticals Recent Developments and Future Plans
2.9 Noven Pharmaceuticals
2.9.1 Noven Pharmaceuticals Details
2.9.2 Noven Pharmaceuticals Major Business
2.9.3 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
2.9.4 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Noven Pharmaceuticals Recent Developments and Future Plans
2.10 Purdue Parma
2.10.1 Purdue Parma Details
2.10.2 Purdue Parma Major Business
2.10.3 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
2.10.4 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Purdue Parma Recent Developments and Future Plans
2.11 CTFH
2.11.1 CTFH Details
2.11.2 CTFH Major Business
2.11.3 CTFH Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
2.11.4 CTFH Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 CTFH Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Attention Deficit Hyperactivity Disorder (ADHD) by Company Revenue
3.2.2 Top 3 Attention Deficit Hyperactivity Disorder (ADHD) Players Market Share in 2023
3.2.3 Top 6 Attention Deficit Hyperactivity Disorder (ADHD) Players Market Share in 2023
3.3 Attention Deficit Hyperactivity Disorder (ADHD) Market: Overall Company Footprint Analysis
3.3.1 Attention Deficit Hyperactivity Disorder (ADHD) Market: Region Footprint
3.3.2 Attention Deficit Hyperactivity Disorder (ADHD) Market: Company Product Type Footprint
3.3.3 Attention Deficit Hyperactivity Disorder (ADHD) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value and Market Share by Type (2019-2024)
4.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast by Type (2025-2030)

5 Market Size Segment by Distribution Channel
5.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Distribution Channel (2019-2024)
5.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast by Distribution Channel (2025-2030)

6 North America
6.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2019-2030)
6.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2019-2030)
6.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country
6.3.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Country (2019-2030)
6.3.2 United States Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
6.3.3 Canada Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
6.3.4 Mexico Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)

7 Europe
7.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2019-2030)
7.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2019-2030)
7.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country
7.3.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Country (2019-2030)
7.3.2 Germany Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
7.3.3 France Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
7.3.5 Russia Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
7.3.6 Italy Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)

8 Asia-Pacific
8.1 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2019-2030)
8.3 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region
8.3.1 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Region (2019-2030)
8.3.2 China Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
8.3.3 Japan Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
8.3.4 South Korea Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
8.3.5 India Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
8.3.7 Australia Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)

9 South America
9.1 South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2019-2030)
9.2 South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2019-2030)
9.3 South America Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country
9.3.1 South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Country (2019-2030)
9.3.2 Brazil Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
9.3.3 Argentina Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)

10 Middle East & Africa
10.1 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2019-2030)
10.3 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country
10.3.1 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Country (2019-2030)
10.3.2 Turkey Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)
10.3.4 UAE Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast (2019-2030)

11 Market Dynamics
11.1 Attention Deficit Hyperactivity Disorder (ADHD) Market Drivers
11.2 Attention Deficit Hyperactivity Disorder (ADHD) Market Restraints
11.3 Attention Deficit Hyperactivity Disorder (ADHD) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry

12 Industry Chain Analysis
12.1 Attention Deficit Hyperactivity Disorder (ADHD) Industry Chain
12.2 Attention Deficit Hyperactivity Disorder (ADHD) Upstream Analysis
12.3 Attention Deficit Hyperactivity Disorder (ADHD) Midstream Analysis
12.4 Attention Deficit Hyperactivity Disorder (ADHD) Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel, (USD Million), 2019 & 2023 & 2030
Table 3. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Takeda Company Information, Head Office, and Major Competitors
Table 6. Takeda Major Business
Table 7. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 8. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Takeda Recent Developments and Future Plans
Table 10. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 11. Johnson & Johnson Major Business
Table 12. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 13. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Johnson & Johnson Recent Developments and Future Plans
Table 15. Novartis Company Information, Head Office, and Major Competitors
Table 16. Novartis Major Business
Table 17. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 18. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Novartis Recent Developments and Future Plans
Table 20. Eli Lilly Company Information, Head Office, and Major Competitors
Table 21. Eli Lilly Major Business
Table 22. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 23. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Eli Lilly Recent Developments and Future Plans
Table 25. Tris Pharma Company Information, Head Office, and Major Competitors
Table 26. Tris Pharma Major Business
Table 27. Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 28. Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Tris Pharma Recent Developments and Future Plans
Table 30. Neos Therapeutics Company Information, Head Office, and Major Competitors
Table 31. Neos Therapeutics Major Business
Table 32. Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 33. Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Neos Therapeutics Recent Developments and Future Plans
Table 35. Mallinckrodt Company Information, Head Office, and Major Competitors
Table 36. Mallinckrodt Major Business
Table 37. Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 38. Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Mallinckrodt Recent Developments and Future Plans
Table 40. Amneal Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 41. Amneal Pharmaceuticals Major Business
Table 42. Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 43. Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Amneal Pharmaceuticals Recent Developments and Future Plans
Table 45. Noven Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 46. Noven Pharmaceuticals Major Business
Table 47. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 48. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Noven Pharmaceuticals Recent Developments and Future Plans
Table 50. Purdue Parma Company Information, Head Office, and Major Competitors
Table 51. Purdue Parma Major Business
Table 52. Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 53. Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Purdue Parma Recent Developments and Future Plans
Table 55. CTFH Company Information, Head Office, and Major Competitors
Table 56. CTFH Major Business
Table 57. CTFH Attention Deficit Hyperactivity Disorder (ADHD) Product and Solutions
Table 58. CTFH Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. CTFH Recent Developments and Future Plans
Table 60. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue (USD Million) by Players (2019-2024)
Table 61. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Players (2019-2024)
Table 62. Breakdown of Attention Deficit Hyperactivity Disorder (ADHD) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Attention Deficit Hyperactivity Disorder (ADHD), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 64. Head Office of Key Attention Deficit Hyperactivity Disorder (ADHD) Players
Table 65. Attention Deficit Hyperactivity Disorder (ADHD) Market: Company Product Type Footprint
Table 66. Attention Deficit Hyperactivity Disorder (ADHD) Market: Company Product Application Footprint
Table 67. Attention Deficit Hyperactivity Disorder (ADHD) New Market Entrants and Barriers to Market Entry
Table 68. Attention Deficit Hyperactivity Disorder (ADHD) Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (USD Million) by Type (2019-2024)
Table 70. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Share by Type (2019-2024)
Table 71. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Forecast by Type (2025-2030)
Table 72. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2019-2024)
Table 73. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Forecast by Distribution Channel (2025-2030)
Table 74. North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2019-2024) & (USD Million)
Table 75. North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2025-2030) & (USD Million)
Table 76. North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2019-2024) & (USD Million)
Table 77. North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2025-2030) & (USD Million)
Table 78. North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Country (2019-2024) & (USD Million)
Table 79. North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Country (2025-2030) & (USD Million)
Table 80. Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2019-2024) & (USD Million)
Table 83. Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2025-2030) & (USD Million)
Table 84. Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2019-2024) & (USD Million)
Table 87. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2025-2030) & (USD Million)
Table 88. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2019-2024) & (USD Million)
Table 89. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2025-2030) & (USD Million)
Table 90. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Region (2019-2024) & (USD Million)
Table 91. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Region (2025-2030) & (USD Million)
Table 92. South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2019-2024) & (USD Million)
Table 93. South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2025-2030) & (USD Million)
Table 94. South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2019-2024) & (USD Million)
Table 95. South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2025-2030) & (USD Million)
Table 96. South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Country (2019-2024) & (USD Million)
Table 97. South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2019-2024) & (USD Million)
Table 99. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type (2025-2030) & (USD Million)
Table 100. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2019-2024) & (USD Million)
Table 101. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Distribution Channel (2025-2030) & (USD Million)
Table 102. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Country (2019-2024) & (USD Million)
Table 103. Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Country (2025-2030) & (USD Million)
Table 104. Attention Deficit Hyperactivity Disorder (ADHD) Raw Material
Table 105. Key Suppliers of Attention Deficit Hyperactivity Disorder (ADHD) Raw Materials
List of Figures
Figure 1. Attention Deficit Hyperactivity Disorder (ADHD) Picture
Figure 2. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Type in 2023
Figure 4. Stimulant
Figure 5. Non-stimulant
Figure 6. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Distribution Channel in 2023
Figure 8. Hospital Pharmacy Picture
Figure 9. Retail Pharmacy Picture
Figure 10. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Market Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 13. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Region (2019-2030)
Figure 14. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Region in 2023
Figure 15. North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 16. Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 17. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 18. South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 19. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 20. Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Players in 2023
Figure 21. Attention Deficit Hyperactivity Disorder (ADHD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 22. Global Top 3 Players Attention Deficit Hyperactivity Disorder (ADHD) Market Share in 2023
Figure 23. Global Top 6 Players Attention Deficit Hyperactivity Disorder (ADHD) Market Share in 2023
Figure 24. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Share by Type (2019-2024)
Figure 25. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share Forecast by Type (2025-2030)
Figure 26. Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Share by Distribution Channel (2019-2024)
Figure 27. Global Attention Deficit Hyperactivity Disorder (ADHD) Market Share Forecast by Distribution Channel (2025-2030)
Figure 28. North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Type (2019-2030)
Figure 29. North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Distribution Channel (2019-2030)
Figure 30. North America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Country (2019-2030)
Figure 31. United States Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 32. Canada Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 33. Mexico Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 34. Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Type (2019-2030)
Figure 35. Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Distribution Channel (2019-2030)
Figure 36. Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Country (2019-2030)
Figure 37. Germany Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 38. France Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 39. United Kingdom Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 40. Russia Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 41. Italy Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 42. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Type (2019-2030)
Figure 43. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Distribution Channel (2019-2030)
Figure 44. Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Region (2019-2030)
Figure 45. China Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 46. Japan Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 47. South Korea Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 48. India Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 49. Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 50. Australia Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 51. South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Type (2019-2030)
Figure 52. South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Distribution Channel (2019-2030)
Figure 53. South America Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Country (2019-2030)
Figure 54. Brazil Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 55. Argentina Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 56. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Type (2019-2030)
Figure 57. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Distribution Channel (2019-2030)
Figure 58. Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Country (2019-2030)
Figure 59. Turkey Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 60. Saudi Arabia Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 61. UAE Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
Figure 62. Attention Deficit Hyperactivity Disorder (ADHD) Market Drivers
Figure 63. Attention Deficit Hyperactivity Disorder (ADHD) Market Restraints
Figure 64. Attention Deficit Hyperactivity Disorder (ADHD) Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Attention Deficit Hyperactivity Disorder (ADHD) in 2023
Figure 67. Manufacturing Process Analysis of Attention Deficit Hyperactivity Disorder (ADHD)
Figure 68. Attention Deficit Hyperactivity Disorder (ADHD) Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
CTFH
jiaGou

Add To Cart

gouMai

Buy Now